KMT2A and prostate cancer: In support of our findings, recent studies have reported that Menin, a critical co‐activator of androgen receptor (AR), along with MLL complex is recruited to the promoter of AR by BAP18 to promote its transcriptional activation and drive prostate cancers (Iba et al., 1985; Malik et al., 2015; Shaw et al., 2018).